Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$408K Sell
8,442
-658
-7% -$32.5K 0.23% 108
2022
Q1
$498K Sell
9,100
-4,021
-31% -$195K 0.14% 187
2021
Q4
$625K Sell
13,121
-530
-4% -$23.4K 0.15% 150
2021
Q3
$538K Buy
13,651
+7,653
+128% +$297K 0.13% 174
2021
Q2
$234K Buy
+5,998
New +$238K 0.05% 358

Other funds holding KBR

Exane Derivatives's KBR Position: Q2 2022 in Review

Exane Derivatives reduced its KBR (KBR) stake by 7.2% in Q2 2022, selling an estimated $32.5K and leaving 8,442 shares worth $408K. The position accounts for 0.23% of the portfolio, ranked #108.

Exane Derivatives first reported a position in KBR in Q2 2021 and has held it in 5 quarters since. The position peaked at $625K in Q4 2021. 337 funds tracked by Wall St. Rank hold KBR as of Q2 2022.

  • Exane Derivatives held 8,442 shares of KBR worth $408K as of Q2 2022.
  • Exane Derivatives sold 658 KBR shares in Q2 2022, an estimated $32.5K.
  • KBR made up 0.23% of Exane Derivatives's portfolio in Q2 2022, its #108 holding.
  • Exane Derivatives first reported a position in KBR in Q2 2021 and has held it in 5 quarters since.
  • Exane Derivatives's KBR position peaked at $625K in Q4 2021.
  • 337 funds tracked by Wall St. Rank held KBR as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.